Dott. Marco Cosentino

Specialista in Urologia e Andrologia

Andrologo e Urologo presso Strutture Private. 2016-ad oggi

Andrologo dell’Unità di Infertilità, Riproduzione Assistita e Salute dell’Uomo e della Donna, presso Fertilab e Dexeus, Barcelona, Spain. 2015-ad oggi

Fellow dell’Unità di Andrologia, Fundaciò Puigvert, Universitat Autonoma de Barcelona, Barcelona, Spain. 2013-2015

Consultant Urologist dell’Unità di Urodinamica e Incontinenza Maschile e Femminile presso la Fundació Puigvert – Universitat Autonoma de Barcelona, Barcelona, Spain. 2012-2013

Consultant Urologist presso le Unità di Uro-Oncolgia, Urologia Pediatrica ed Endoscopia della Fundaciò Puigvert, Universitat Autonoma de Barcelona, Barcelona, Spain. 2012

Consultant Urologist dell’Unità di Urologia Pediatrica della Fundaciò Puigvert, Universitat Autonoma de Barcelona, Barcelona, Spain. 2011-2012

Consultant Urologist dell’Unità di Urodinamica e Incontinenza Maschile e Femminile presso la Fundació Puigvert – Universitat Autonoma de Barcelona, Barcelona, Spain. 2010-2011

Fellow dell’Unità di Uro-Oncologia della Fundaciò Puigvert, Universitat Autonoma de Barcelona, Barcelona, Spain. 2009-2010

Laureato in Medicina e Chirurgia presso l’Università degli Studi di Catania. 2003

Specializzazione in Urologia presso l’Università degli Studi di Padova. 2009

Specializzazione in Andrologia presso l’Universitat Autonoma de Barcelona. 2013-2015

Master di II livello in Andrologia e Medicina della Sessualità presso l’Università di Padova. 2016

Cosentino M, Kanashiro A, Vives A, Sanchez J, Peraza MF, Moreno D, Perona J, De Marco V, Ruiz-Castañe E, Sarquella J. Surgical treatment of Peyronie’s disease with small intestinal submucosa graft patch. Int J Impot Res. 2016 Mar 31. doi: 10.1038/ijir.2016.10.

• Cosentino V, Fratter A, Cosentino M. Anti-inflammatory effects exerted by Killox®, an innovative formulation of food supplement with curcumin, in urology. Eur Rev Med Pharmacol Sci. 2016 Apr;20(7):1390-8.

• Vives A, Vazquez A, Rajmil O, Cosentino M. Urethral condylomas in men: experience in 123 patients without previous treatment. Int J STD AIDS. 2015 Feb 22. pii: 0956462415574627.

• Cosentino M, Sarquella J, Ruiz Castañe E. PRIAPISM SECONDARY TO TAMSULOSIN: A CASE REPORT. Revista International de Andrologia Jul 2014. DOI: 10.1016/j.androl.2014.07.007

• Cosentino M, Algaba F, Saldaña L, Bujons A, Caffaratti J, Garat JM, Villavicencio H. JUVENILE GRANULOSA CELL TUMOR OF THE TESTIS: A BILATERAL AND SYNCHRONOUS CASE: SHOULD TESTIS-SPARING SURGERY BE MANDATORY? Urology. 2014 Sep;84(3):694-6. doi: 10.1016/j.urology.2014.05.006. Epub 2014 Jul 19.

• Cosentino M, Caffaratti J, Bujons A, Garat JM, Villavicencio H. TRATAMIENTO ENDOSCOPICO DEL REFLUJO VESICO-URETERAL. Published in “Focus” n.6, May 2014, 25-28.

• Cosentino M, Caffaratti J, Bujons A, Garat JM, Villavicencio H. VESICO-URETERAL REFUX, ENDOSCOPIC MANAGEMENT. Arch Argent Pediatr. 2013 Aug;111(4):349-52. doi: 10.1590/S0325- 00752013000400021.

• Cosentino M.: ” ALLOPLASTIC BLADDER SUBSTITUTION: ARE WE MAKING PROGRESS?”. UroToday.com Beyond the Abstract initiative. Published on Wednesday, January 9, 2013 online at http://www.urotoday.com/index.php?option=com_content&Itemid=813&catid=1160&id=56696&lang= en&view=article.

• Cosentino M, Breda A, Sanguedolce F, Landman J, Stolzenburg J-U, Verze P, Rassweiler J, Van Poppel H, Klingler HC, Janetschek G, Celia A, Kim FJ, Thalmann G, Nagele U, Mogorovich A, Bolenz C, Knoll T, Porpiglia F, Alvarez-Maestro M, Francesca F, Deho F, Eggener S, Abbou C, Meng MV, Aron M, Laguna P, Mladenov D, D’Addessi A, Bove P, Schiavina R, De Cobelli O, Merseburger AS, Dalpiaz O, D’Ancona FCH, Polascik TJ, Muschter R, Leppert TJ,Villavicencio H. THE USE OF MANNITOL IN PARTIAL AND LIVE DONOR NEPHRECTOMY: AN INTERNATIONAL SURVEY. World J Urol. 2013 Aug;31(4):977-82. doi: 10.1007/s00345-012-1003-1. Epub 2012 Dec 15.

• Cosentino M, Gaya J.M., Breda A, Palou J, Villavicencio H: ALLOPLASTIC BLADDER SUBSTITUTION: ARE WE MAKING PROGRESS? Int Urol Nephrol. Oct;44(5):1295-303. doi: 10.1007/s11255-012-0249-2. Epub 2012 Jul 21.0

• Gaya JM, Palou J, Cosentino M, Patiño D, Rodríguez-Faba O, Villavicencio H. A SECOND TRANSURETHRAL RESECTION COULD BE NOT NECESSARY IN ALL HUGH GRADE NONMUSCLE-INVASIVE BLADDER TUMORS. Actas Urol Esp. Vol 36, Num 9, 2012 English, Spanish.

• Cosentino M, Palou-Redorta J, Gaya-Sopena JM, Gich I, Breda A, Rodriguez-Faba O, VillavicencioMavrich H.: INCIDENCE OF BLADDER TUMOR IN PRIMARY UPPER URINARY TRACT TUMORS: LOCALIZATION OF UPPER TRACT TUMOR AS A PREDICTIVE FACTOR. World J Urol. Epub 2012 May 3.

• Cosentino M, A Breda, Sánchez-Martín FM, J Palou, J Caffaratti, H Villavicencio. “¿ES POSIBLE UNA VEJIGA ARTIFICIAL? PROGRESOS EN LAS ÚLTIMAS DÉCADAS”. Actas Fundació Puigvert Vol- 31, n.2-2012 pag 41-52.

• J Caffaratti Sfulcini, JR Perez Carral, M Cosentino, A Bujons, JM Garat Barredo, H Villavicencio Mavrich. ACTUALIZACIÓN EN EL MANEJO DE LA LITIASIS PEDIÁTRICA. Rev Esp Pediatr 2012; 68(4): 295-301.

• Joan Palou Redorta, Merce Pascual, Marco Cosentino, Juan Ignacio Caicedo, Oscar Rodriguez, Humberto Villavicencio. EFFECT OF RETENTION TIME ON NMP22 BLADDER CHECK ASSAY RESULTS IN VOIDED URINE. Nephro-Urol Mon. 2011;3(3):182-185

• Juan A. Peña, Miriam Serrano, Marco Cosentino, Antonio Rosales, Ferran Algaba, Juan Palou, Humberto Villavicencio. LAPAROSCOPIC MANAGEMENT OF SPONTANEOUS RETROPERITONEAL HEMORRHAGE. Urol Int. 2011;87(1):114-6. Epub 2011 Apr 27.

• Juan Palou, Mercè Pascual, Marco Cosentino, Juan Ignacio Caicedo, Orsac Rodriguez, Hmberto Villavicencio. COMPARING THE EFFECT OF DIFFERENT RETENTION TIMES ON NMP22 BLADDER CHECK ASSAY RESULTS IN VOIDED URINE. Nephro-Urol Mon 2011; 3 (3) 182-185.

• Santillana Josep.Mª, Angerri Oriol, Caffaratti Jorge, Cosentino Marco, Villavicencio Humberto. RABDOMIOSARCOMA EMBRIONARI DE PROSTATA. PRESENTACIO D’UN CAS I SEGUIMENT DEL PACIENT AMB UNA URETEROSTOMIA CUTANIA. Annals d’Urologia. Vol. 37 Núm. 1, 2011.

• O. Rodríguez Faba, J. Palou, E. Gómez, L. Gausa, M. Cosentino, H. Villavicencio. MARCADORES TUMORALES URINARIOS PARA EL CANCER VESICAL. Actas Fund Puigvert 2010,29(2):54-60

• Pardo P., Rodriguez-Faba O., Rosales A., Palou J., Salas F., Azuero J., Ruiz-Tagle D., Gaya JM., Cosentino M., Gausa L., Esquena S., Peña A., Villavicencio H. ACTUALIZACION EN EL TRATAMIENTO MEDICO DEL CARCINOMA RENAL AVANZADO. Actas Fundaciò Puigvert 2010, Vol 29 Num 1:14-19.

• Johannsen M., Florkern A., Bex A., Roigas J., Cosentino M., Ficarra V., Kloeters C., Rief M., Rogalla P., Miller K., Grunwald V.: CAN TYROSINE CHINASE INIBITORS BE DISCONTINUED IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AND A COMPLETE RESPONDE TO TREATMENT? A MULTICENTER, RETROSPECTIVE ANALYSIS. Eur Urol. 2009 Jun;55(6):1430-8. Epub 2008 Oct 18.

• Galfano A., Novara G., Iafrate M., De Marco V., Cosentino M., D’Elia C., Artibani W., Ficarra V. : IMPROVEMENT OF SEMINAL PARAMETERS AND PREGNANCY RATES AFTER ANTEGRADE SCLEROTHERAPY OF INTERNAL SPERMATIC VEINS. Fertil Steril. 2009 Apr;91(4):1085-9. Epub 2008 Jul 21.

• Galfano A., Novara G., Iafrate M., Cosentino M., Cavalleri S., Artibani W, Ficarra V.. PROSTATE BIOPSY: THE TRANSPERINEAL APPROACH EAU–EBU Update Series 5 (2007) 241–249.

• Dal Moro F., Capizzi A., Rigamonti W., Cosentino M., Cisternino A., Prayer Galetti T., Artibani W.: IS PERCUTANEOUS NEPHROLITHOTOMY A SAFE AND EFFECTIVE PROCEDURE FOR TREATMENT OF RENAL STONES IN CHILDREN? European Urology Supplements 2006; 5 (2): 111. Abstract 353.